Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other financing activities (2021 - 2022)

Historic Other financing activities for Rani Therapeutics Holdings (RANI) over the last 2 years, with Q4 2022 value amounting to $152000.0.

  • Rani Therapeutics Holdings' Other financing activities changed N/A to $152000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $260000.0, marking a year-over-year change of. This contributed to the annual value of $260000.0 for FY2022, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Other financing activities of $152000.0 as of Q4 2022.
  • Over the past 5 years, Rani Therapeutics Holdings' Other financing activities peaked at $2.2 million during Q2 2021, and registered a low of -$1.9 million during Q3 2021.